Persistent Borrelia burgdorferi infection after treatment with antibiotics and anti-tumor necrosis factor-alpha.
Stricker
Raphael B
RB
Johnson
Lorraine
L
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000906:Antibodies / Q000494:pharmacology* / Q000627:therapeutic use; D025065:Borrelia burgdorferi / Q000187:drug effects / Q000472:pathogenicity / Q000502:physiology*; D008193:Lyme Disease / Q000188:drug therapy*; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors* / Q000276:immunology
D000900:Anti-Bacterial Agents; D000906:Antibodies; D014409:Tumor Necrosis Factor-alpha